In-vitro and ex-vivo antidiabetic, and antioxidant activities of Box-Behnken design optimized Solanum xanthocarpum extract loaded niosomes
Saudi Pharmaceutical Journal · 2023-10 · 31 (10) · 101785
DOI: 10.1016/j.jsps.2023.101785 ↗Kurz gefasst
Fachartikel in der Zeitschrift Saudi Pharmaceutical Journal, 2023-10. Verfasst von Rama Tyagi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Amity Institute of Pharmacy, Amity University, Noida, Uttar Pradesh 201301, India. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Education – Kingdom of Saudi Arabi.
Abstract (Originalsprache)
One of the most prevalent lifestyle diseases, diabetes mellitus (DM) is brought on by an endocrine issue. DM is frequently accompanied by hyperglycemia, a disease that typically results in an excess of free radicals that stress tissues. The medical community is currently concentrating on creating therapeutic medications with roots in nature to lessen the damage associated with hyperglycemia. Solanum xanthocarpum has a number of medicinal benefits. The investigation aimed to produce and analyze niosomal formulations containing S. xanthocarpum extract (SXE). Niosomes were made by implementing the solvent evaporation process, which was further optimized using Box-Behnken design. Drug release, DPPH assessments, α-amylase inhibition assay, α-glucosidase inhibition assay, and confocal laser scanning microscopy (CLSM) investigation were all performed on the developed formulation (SXE-Ns-Opt). SXE-Ns-Opt displayed a 253.6 nm vesicle size, a PDI of 0.108, 62.4% entrapment efficiency, and 84.01% drug release in 24 h. The rat's intestinal CLSM image indicated that the rhodamine red B-loaded SXE-Ns-Opts had more intestinal penetration than the control. Additionally, the antioxidant effect of the obtained formulation was demonstrated as 89.46% as compared to SXE (78.10%). Additionally, acarbose, SXE, and SXE-Ns-Opt each inhibited the activity of α-amylase by 95.11%, 85.88%, and 89.87%, and also suppressed the enzyme of α-glucosidase by 88.47%, 81.07%, and 85.78%, respectively. To summarise, the establishment of the SXE-Ns-Opt formulation and its characterization demonstrated the legitimacy of the foundation. A promising candidate for the treatment of diabetes mellitus has been shown as in vitro studies, antioxidant against oxidative stress, CLSM of rat's intestine and a high degree of penetration of formulation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Amity Institute of Pharmacy, Amity University, Noida, Uttar Pradesh 201301, India.
- Department of Pharmaceutics, SPER, Jamia Hamdard, New Delhi 110062, India.
- Department of Pharmacognosy and Phytochemistry, SPER, Jamia Hamdard, New Delhi 110062, India.
- Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.
- Department of Periodontics, College of Dentistry, University of Illinois Chicago, Chicago, IL 60612, USA.
- Department of Pharmacognosy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.
Förderung
- Ministry of Education – Kingdom of Saudi Arabi
Zitieren
APA
Tyagi, R., Waheed, A., Kumar, N., Mujeeb, M., Naved, T., Rashid Khan, M., Alhosaini, K., Alqarni, Y. A., Rahat, R., Alam, P., & Madan, S. (2023). In-vitro and ex-vivo antidiabetic, and antioxidant activities of Box-Behnken design optimized Solanum xanthocarpum extract loaded niosomes. Saudi Pharmaceutical Journal, 31(10), 101785. https://doi.org/10.1016/j.jsps.2023.101785
Vancouver
Tyagi R, Waheed A, Kumar N, Mujeeb M, Naved T, Rashid Khan M, et al. In-vitro and ex-vivo antidiabetic, and antioxidant activities of Box-Behnken design optimized Solanum xanthocarpum extract loaded niosomes. Saudi Pharmaceutical Journal. 2023;31(10):101785. doi:10.1016/j.jsps.2023.101785
BibTeX
@article{Tyagi2023,
author = {Tyagi, Rama and Waheed, Ayesha and Kumar, Neeraj and Mujeeb, Mohd and Naved, Tanveer and Rashid Khan, Mohammad and Alhosaini, Khaled and Alqarni, Yasser A and Rahat, Rani and Alam, Perwez and Madan, Swati},
title = {In-vitro and ex-vivo antidiabetic, and antioxidant activities of Box-Behnken design optimized Solanum xanthocarpum extract loaded niosomes},
journal = {Saudi Pharmaceutical Journal},
year = {2023},
volume = {31},
number = {10},
pages = {101785},
doi = {10.1016/j.jsps.2023.101785}
}
EUVIMED